Human p38δ MAP kinase mediates UV irradiation induced up-regulation of the gene expression of chemokine BRAK/CXCL14

Biochemical and Biophysical Research Communications

Volumn 396, Issue 4, 2010, Pages 1060-1064

  Ozawa, Shigeyuki ^a,b,c   Ito, Shin ^a,b   Kato, Yasumasa ^a,b   Kubota, Eiro ^b,c   Hata, Ryu Ichiro ^a,b  

^a Oral Health Science Research Center   (Japan)

^b Department of Biochemistry and Molecular Biology ^*  (Japan)

^c KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Chemokine BRAK CXCL14; Cytokine; p38 isoform specificity; p38 ; Serum deprivation; UV irradiation

Indexed keywords

CXCL14 CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 13; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ULTRAVIOLET IRRADIATION; UPREGULATION;

CELL LINE, TUMOR; CHEMOKINES, CXC; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 13; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 77953286924     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.05.072     Document Type: Article

References (22)

1. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
2. Avruch J. MAP kinase pathways: the first twenty years. Biochim. Biophys. Acta 1773 (2007) 1150-1160
3. Wagner E.F., and Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9 (2009) 537-549
4. Zlotnik A., Yoshie O., and Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 7 (2006) 243
5. Meuter S., and Moser B. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues. Cytokine 44 (2008) 248-255
6. Kurth I., Willimann K., Schaerli P., Hunziker T., Clark-Lewis I., and Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194 (2001) 855-861
7. Schaerli P., Willimann K., Ebert L.M., Walz A., and Moser B. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23 (2005) 331-342
8. Starnes T., Rasila K.K., Robertson M.J., Brahmi Z., Dahl R., Christopherson K., and Hromas R. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp. Hematol. 34 (2006) 1101-1105
9. Nara N., Nakayama Y., Okamoto S., Tamura H., Kiyono M., Muraoka M., Tanaka K., Taya C., Shitara H., Ishii R., Yonekawa H., Minokoshi Y., and Hara T. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J. Biol. Chem. 282 (2007) 30794-30803
10. Shellenberger T.D., Wang M., Gujrati M., Jayakumar A., Strieter R.M., Burdick M.D., Ioannides C.G., Efferson C.L., El-Naggar A.K., Roberts D., Clayman G.L., and Frederick M.J. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res. 64 (2004) 8262-82270
11. Ozawa S., Kato Y., Komori R., Maehata Y., Kubota E., and Hata R. BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells. Biochem. Biophys. Res. Commun. 348 (2006) 406-412
12. Ozawa S., Kato Y., Ito S., Komori R., Shiiki N., Tsukinoki K., Ozono S., Maehata Y., Taguchi T., Imagawa-Ishiguro Y., Tsukuda M., Kubota E., and Hata R.I. Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma. Cancer Sci. 100 (2009) 2202-2209
13. Xiao Y.Q., Malcolm K., Worthen G.S., Gardai S., Schiemann W.P., Fadok V.A., Bratton D.L., and Henson P.M. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-β. J. Biol. Chem. 277 (2002) 14884-14893
14. Avitzour M., Diskin R., Raboy B., Askari N., Engelberg D., and Livnah O. Intrinsically active variants of all human p38 isoforms. Febs. J. 274 (2007) 963-975
15. Ventura J.J., Tenbaum S., Perdiguero E., Huth M., Guerra C., Barbacid M., Pasparakis M., and Nebreda A.R. P38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39 (2007) 750-758
16. Trouillas M., Saucourt C., Duval D., Gauthereau X., Thibault C., Dembele D., Feraud O., Menager J., Rallu M., Pradier L., and Boeuf H. Bcl2, a transcriptional target of p38α, is critical for neuronal commitment of mouse embryonic stem cells. Cell Death Differ. 15 (2008) 1450-1459
17. Raman D., Baugher P.J., Thu Y.M., and Richmond A. Role of chemokines in tumor growth. Cancer Lett. 256 (2007) 137-165
18. Hromas R., Broxmeyer H.E., Kim C., Nakshatri H., Christopherson II K., Azam M., and Hou Y.H. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 255 (1999) 703-706
19. Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., Lewis D.E., El-Naggar A.K., and Clayman G.L. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am. J. Pathol. 156 (2000) 1937-1950
20. Ozawa S., Kato Y., Kubota E., and Hata R. BRAK/CXCL14 expression in oral carcinoma cells completely suppresses tumor cell xenografts in SCID mouse. Biomed. Res. 30 (2009) 315-318
21. Efimova T., Broome A.M., and Eckert R.L. A regulatory role for p38δ MAPK in keratinocyte differentiation Evidence for p38δ-ERK1/2 complex formation. J. Biol. Chem. 278 (2003) 34277-34285
22. Komori R., Ozawa S., Kato Y., Shinji H., Kimoto S., and Hata R. Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine. Biomed. Res. 31 (2010) 123-131